Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels

Overview of attention for article published in Respiratory Research, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 5 news stories from 5 outlets.

By: GlobenewsWire - 25 May 2021 NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global…

(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

GlobeNewswire 2021-05-25 NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…

(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 1 additional news stories.